New study to combat the most common form of liver cancer

October 12, 2012

Scientists at the University of Southampton are to investigate the best way to use natural killer cells (NK) to target the most common form of liver cancer.

are able to directly kill cancer in the body and stimulate other cells in the immune system to help attack cancer.

At the moment, NK cells, and the chemicals that manipulate them, are being used to treat a variety of different cancers, mainly cancers of the blood.

However there is growing evidence that these cells could be used to create an to hepatocellular cancer (HCC) cells and be used to kill them.

HCC is the most common form of and is mainly caused by cirrhosis of the liver – where the liver has become scarred as a result of damage over a long period of time.

Funded by the British Liver Trust, researchers at the University of Southampton will investigate how to manipulate NK cells to attack HCC cells.

The University's Salim Khakoo, Professor of and Aymen Al-Shamkhani, Professor in Immunology will be leading the study.

Professor Khakoo explains: "Hepatocellular cancer accounts for 90 per cent of all primary liver cancers and is an extremely difficult condition to treat. At this early stage of the study we aim to create a method to form the basis for a clinical trial to use NK cells to treat HCC.

"To do this we will study patients with HCC and then use three different stimuli to activate NK cells. These different include a chemical stimulant of NK cells and antibodies that target molecules on the surface of the NK cells. By trying different combinations of these chemicals and antibodies together, we will be able to develop an optimal method to use them for ."

When the team has developed a successful method for stimulating the NK cells, tests will be carried out to determine the best way to use them for an anti-cancer effect.

Andrew Langford, Chief Executive of the British Liver Trust commented "The British Liver Trust is delighted to fund what we hope will be invaluable research for new treatment of liver cancer. Unfortunately, of the big five killer diseases, deaths from liver cancer is the only one that continues to increase and the average age at which people die of a liver disease is now 59 and this gets lower each year; consequently, any research into new treatments offers hope that we can treat those that have liver cancer more effectively."

Explore further: Research in fish provides new clues about deadly form of liver cancer

Related Stories

Research in fish provides new clues about deadly form of liver cancer

July 5, 2011
Hepatocellular carcinoma (HCC), the most common type of liver cancer, is a leading cause of cancer-related deaths worldwide. Although there are several treatment options available, they are largely unsuccessful because the ...

miR-122: Loss of tiny liver molecule might lead to liver cancer

July 23, 2012
A new study shows that loss of a small RNA molecule in liver cells might cause liver cancer and that restoring the molecule might slow tumor growth and offer a new way to treat the disease.

Recommended for you

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.